Predicting mTOR inhibitors with a classifier using recursive partitioning and Naïve Bayesian approaches

Mammalian target of rapamycin (mTOR) is a central controller of cell growth, proliferation, metabolism, and angiogenesis. Thus, there is a great deal of interest in developing clinical drugs based on mTOR. In this paper, in silico models based on multi-scaffolds were developed to predict mTOR inhibi...

Ausführliche Beschreibung